PetMed Express (NASDAQ:PETS) Shares Cross Above 200 Day Moving Average – Time to Sell?

PetMed Express, Inc. (NASDAQ:PETS) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.85 and traded as high as $3.38. PetMed Express shares last traded at $3.38, with a volume of 109,629 shares changing hands.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on PETS shares. Weiss Ratings reissued a “sell (e+)” rating on shares of PetMed Express in a report on Monday, December 29th. Zacks Research raised shares of PetMed Express from a “strong sell” rating to a “hold” rating in a research note on Monday, September 29th. Finally, Wall Street Zen downgraded PetMed Express from a “hold” rating to a “sell” rating in a report on Saturday, October 18th. One investment analyst has rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Sell” and an average target price of $3.20.

PetMed Express Stock Up 2.7%

The business’s 50 day moving average is $2.73 and its two-hundred day moving average is $2.85. The firm has a market cap of $72.23 million, a P/E ratio of -1.28 and a beta of 0.65.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Friday, December 19th. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.45). PetMed Express had a negative net margin of 28.22% and a negative return on equity of 40.26%. The firm had revenue of $44.36 million for the quarter. Equities research analysts anticipate that PetMed Express, Inc. will post 0.19 EPS for the current year.

Hedge Funds Weigh In On PetMed Express

Institutional investors have recently added to or reduced their stakes in the business. CIBC Private Wealth Group LLC bought a new position in shares of PetMed Express during the 3rd quarter worth approximately $75,000. CIBC Bancorp USA Inc. acquired a new position in shares of PetMed Express during the 3rd quarter valued at $153,000. Man Group plc lifted its position in shares of PetMed Express by 7.1% during the 3rd quarter. Man Group plc now owns 151,039 shares of the company’s stock valued at $379,000 after acquiring an additional 9,989 shares during the period. Bridgeway Capital Management LLC boosted its stake in PetMed Express by 164.3% during the third quarter. Bridgeway Capital Management LLC now owns 107,816 shares of the company’s stock worth $271,000 after acquiring an additional 67,016 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in PetMed Express by 5.4% in the third quarter. Dimensional Fund Advisors LP now owns 481,517 shares of the company’s stock worth $1,209,000 after purchasing an additional 24,624 shares during the period. 73.33% of the stock is owned by institutional investors and hedge funds.

About PetMed Express

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.